Renbing Jia

6.9k citations
174 papers · 4.4k indexed · 3 hit papers · h-index 35
Topics
Ocular Oncology and Treatments (62 papers)Nonmelanoma Skin Cancer Studies (16 papers)Cancer-related molecular mechanisms research (15 papers)

In The Last Decade

Renbing Jia

163 papers receiving 4.4k citations

Hit Papers

Uveal melanoma2019202620212023202020192025100200300400

Peers

Renbing Jia
Comparison fields: 5 of 131
  • Molecular Biology 2.5k
  • Cancer Research 1.4k
  • Ophthalmology 1.0k
  • Oncology 950
  • Immunology 558
Replace Klaus Griewank with:
Klaus Griewank Germany
Jaume Mora Spain
Mohamed H. Abdel‐Rahman United States
Ming Guan China
Armando Bartolazzi Italy
Archana Thakur United States
John M. Herndon United States
Lynn A. Cornelius United States
M. Asif Amin United States
Takayuki Hattori Japan
Renbing Jia relative to Klaus Griewank Germany Klaus Griewank's profile →
Citations per field
00.5×4.5×
Klaus Griewank · 1×
Citations per year

Countries citing papers authored by Renbing Jia

Since Specialization
Citations

This map shows the geographic impact of Renbing Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renbing Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renbing Jia more than expected).

Fields of papers citing papers by Renbing Jia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renbing Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renbing Jia. The network helps show where Renbing Jia may publish in the future.

Co-authorship network of co-authors of Renbing Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Renbing Jia. A scholar is included among the top collaborators of Renbing Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renbing Jia. Renbing Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 7
5 2
6 0
7 3
8 1
9 1
10 4
11 3
12 21
13 0
14 1
15 114
16 3
17 26
18 8
19 34
20 7

About Renbing Jia

Renbing Jia is a scholar working on Ophthalmology, Oncology and Dermatology, having authored 174 papers that have together received 4.4k indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (62 papers), Nonmelanoma Skin Cancer Studies (16 papers) and Cancer-related molecular mechanisms research (15 papers). The work is most often cited by research in Ophthalmology (1.0k citations), Cancer Research (1.4k citations) and Molecular Biology (2.5k citations). Renbing Jia has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Shengfang Ge, Xianqun Fan, Peiwei Chai, Zhi Yang, Qingfeng Shang, Yongyun Li, Ruobing Jia, Shaoyun Wang, Jie Yang and Hanhan Shi. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026